Cost-effectiveness of clinical interventions for AIDS wasting.
Saved in:
| Title: | Cost-effectiveness of clinical interventions for AIDS wasting. |
|---|---|
| Authors: | Beaston-Blaakman, A. (AUTHOR), Shepard, D. S. (AUTHOR), Stone, N. (AUTHOR), Shevitz, A. H. (AUTHOR) |
| Source: | AIDS Care. Sep2007, Vol. 19 Issue 8, p996-1001. 6p. 6 Charts, 1 Graph. |
| Subjects: | Cost effectiveness, Medical care, AIDS prevention, Prevention of sexually transmitted diseases, HIV wasting syndrome, AIDS complications, Nutrition counseling |
| Geographic Terms: | Boston (Mass.), Massachusetts |
| Abstract: | Economic studies of HIV/AIDS interventions are important for providing cost-effective care. This paper presents a costeffectiveness study of a three-arm clinical trial conducted at Tufts University School of Medicine/New England Medical Center in Boston, Massachusetts that treated 50 patients with AIDS wasting from March 1998 through January 2001. This study compared the costs and impacts of a nutritional counseling intervention alone (NC arm), the nutrition intervention with oxandrolone (OX arm), and the nutrition intervention with progressive resistance training (PRTarm) for the treatment of AIDS wasting. The cost of each intervention was derived for both the three-month clinical trial and a six-month estimated community model (ECM), its projected adaptation to community-based medical care. The cost determination involved obtaining and multiplying unit economic costs and quantities expended of each resource within each study arm. The ECM average cost per client in the cost-effectiveness analysis incorporated both institutional and societal perspectives. The costeffectiveness analysis compared the cost of each intervention to its quality-adjusted life-year (QALY) gain (Zeckhauser and Shepard, 1976). From a societal perspective, for the NC arm, the cost per client totaled $983 for the actual and $596 under the ECM. For the OX arm, the cost per client totaled $3,772 for the actual study and $3,385 under the ECM. For the PRT arm, the cost per client totaled $3,189 for the actual study and $2,987 under the ECM. Under the societal perspective the cost per QALY was $55,000 (range: $51,000 to $83,000) for the NC arm, $151,000 (range: $149,000 to $171,000) for the OX arm, and $65,000 (range: $44,000 to $104,000) for the PRTarm. When using only an institutional perspective, the cost per QALY was $45,000 (range: $42,000-$64,000) for the NC arm, $147,000 (range: $147,000 to $163,000) for the OX arm, and $31,000 ($21,000 to $44,000) for the PRTarm. This paper shows that cost and cost-effectiveness analyses can be adapted to a community setting by combining information from community practice and costs with data from a randomized trial. Compared to other AIDS treatments, such as highly active antiretroviral therapies, all three interventions were affordable, but their cost-effectiveness was intermediate. Oxandrolone was the least cost effective of the interventions, even compared to nutrition alone, as it included similar or somewhat greater costs for less of an increase in quality of life. PRT was the most cost-effective treatment for AIDS wasting, particularly from an institutional perspective. Third party payers should consider coverage of PRT. [ABSTRACT FROM AUTHOR] |
| Copyright of AIDS Care is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: pbh DbLabel: Psychology and Behavioral Sciences Collection An: 26548210 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Cost-effectiveness of clinical interventions for AIDS wasting. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Beaston-Blaakman%2C+A%2E%22">Beaston-Blaakman, A.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shepard%2C+D%2E+S%2E%22">Shepard, D. S.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Stone%2C+N%2E%22">Stone, N.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shevitz%2C+A%2E+H%2E%22">Shevitz, A. H.</searchLink> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22AIDS+Care%22">AIDS Care</searchLink>. Sep2007, Vol. 19 Issue 8, p996-1001. 6p. 6 Charts, 1 Graph. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Cost+effectiveness%22">Cost effectiveness</searchLink><br /><searchLink fieldCode="DE" term="%22Medical+care%22">Medical care</searchLink><br /><searchLink fieldCode="DE" term="%22AIDS+prevention%22">AIDS prevention</searchLink><br /><searchLink fieldCode="DE" term="%22Prevention+of+sexually+transmitted+diseases%22">Prevention of sexually transmitted diseases</searchLink><br /><searchLink fieldCode="DE" term="%22HIV+wasting+syndrome%22">HIV wasting syndrome</searchLink><br /><searchLink fieldCode="DE" term="%22AIDS+complications%22">AIDS complications</searchLink><br /><searchLink fieldCode="DE" term="%22Nutrition+counseling%22">Nutrition counseling</searchLink> – Name: SubjectGeographic Label: Geographic Terms Group: Su Data: <searchLink fieldCode="DE" term="%22Boston+%28Mass%2E%29%22">Boston (Mass.)</searchLink><br /><searchLink fieldCode="DE" term="%22Massachusetts%22">Massachusetts</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Economic studies of HIV/AIDS interventions are important for providing cost-effective care. This paper presents a costeffectiveness study of a three-arm clinical trial conducted at Tufts University School of Medicine/New England Medical Center in Boston, Massachusetts that treated 50 patients with AIDS wasting from March 1998 through January 2001. This study compared the costs and impacts of a nutritional counseling intervention alone (NC arm), the nutrition intervention with oxandrolone (OX arm), and the nutrition intervention with progressive resistance training (PRTarm) for the treatment of AIDS wasting. The cost of each intervention was derived for both the three-month clinical trial and a six-month estimated community model (ECM), its projected adaptation to community-based medical care. The cost determination involved obtaining and multiplying unit economic costs and quantities expended of each resource within each study arm. The ECM average cost per client in the cost-effectiveness analysis incorporated both institutional and societal perspectives. The costeffectiveness analysis compared the cost of each intervention to its quality-adjusted life-year (QALY) gain (Zeckhauser and Shepard, 1976). From a societal perspective, for the NC arm, the cost per client totaled $983 for the actual and $596 under the ECM. For the OX arm, the cost per client totaled $3,772 for the actual study and $3,385 under the ECM. For the PRT arm, the cost per client totaled $3,189 for the actual study and $2,987 under the ECM. Under the societal perspective the cost per QALY was $55,000 (range: $51,000 to $83,000) for the NC arm, $151,000 (range: $149,000 to $171,000) for the OX arm, and $65,000 (range: $44,000 to $104,000) for the PRTarm. When using only an institutional perspective, the cost per QALY was $45,000 (range: $42,000-$64,000) for the NC arm, $147,000 (range: $147,000 to $163,000) for the OX arm, and $31,000 ($21,000 to $44,000) for the PRTarm. This paper shows that cost and cost-effectiveness analyses can be adapted to a community setting by combining information from community practice and costs with data from a randomized trial. Compared to other AIDS treatments, such as highly active antiretroviral therapies, all three interventions were affordable, but their cost-effectiveness was intermediate. Oxandrolone was the least cost effective of the interventions, even compared to nutrition alone, as it included similar or somewhat greater costs for less of an increase in quality of life. PRT was the most cost-effective treatment for AIDS wasting, particularly from an institutional perspective. Third party payers should consider coverage of PRT. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of AIDS Care is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=26548210 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/09540120701335238 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 6 StartPage: 996 Subjects: – SubjectFull: Cost effectiveness Type: general – SubjectFull: Medical care Type: general – SubjectFull: AIDS prevention Type: general – SubjectFull: Prevention of sexually transmitted diseases Type: general – SubjectFull: HIV wasting syndrome Type: general – SubjectFull: AIDS complications Type: general – SubjectFull: Nutrition counseling Type: general – SubjectFull: Boston (Mass.) Type: general – SubjectFull: Massachusetts Type: general Titles: – TitleFull: Cost-effectiveness of clinical interventions for AIDS wasting. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Beaston-Blaakman, A. – PersonEntity: Name: NameFull: Shepard, D. S. – PersonEntity: Name: NameFull: Stone, N. – PersonEntity: Name: NameFull: Shevitz, A. H. IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 09 Text: Sep2007 Type: published Y: 2007 Identifiers: – Type: issn-print Value: 09540121 Numbering: – Type: volume Value: 19 – Type: issue Value: 8 Titles: – TitleFull: AIDS Care Type: main |
| ResultId | 1 |